Original Investigation
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer
W. Fraser Symmans, MD; Christina Yau, PhD; Yunn-Yi Chen, MD; Ron Balassanian, MD; Molly E. Klein, MD; Lajos Pusztai, MD; Rita Nanda, MD; Barbara A. Parker, MD; Brian Datnow, MD; Gregor Krings, MD; Shi Wei, MD; Michael D. Feldman, MD; Xiuzhen Duan, MD; Beiyun Chen, MD; Husain Sattar, MD; Laila Khazai, MD; Jay C. Zeck, MD; Sharon Sams, MD; Paulette Mhawech-Fauceglia, MD; Mara Rendi, MD; Sunati Sahoo, MD; Idris Tolgay Ocal, MD; Fang Fan, MD; Lauren Grasso LeBeau, MD; Tuyethoa Vinh, MD; Megan L. Troxell, MD; A. Jo Chien, MD; Anne M. Wallace, MD; Andres Forero-Torres, MD; Erin Ellis, MD; Kathy S. Albain, MD; Rashmi K. Murthy, MD; Judy C. Boughey, MD; Minetta C. Liu, MD; Barbara B. Haley, MD; Anthony D. Elias, MD; Amy S. Clark, MD; Kathleen Kemmer, MD; Claudine Isaacs, MD; Julie E. Lang, MD; Hyo S. Han, MD; Kirsten Edmiston, MD; Rebecca K. Viscusi, MD; Donald W. Northfelt, MD; Qamar J. Khan, MD; Brian Leyland-Jones, MD; Sara J. Venters, PhD; Sonal Shad, BS; Jeffrey B. Matthews, PhD; Smita M. Asare, BS; Meredith Buxton, PhD; Adam L. Asare, PhD; Hope S. Rugo, MD; Richard B. Schwab, MD; Teresa Helsten, MD; Nola M. Hylton, MD; Laura van ’t Veer, PhD; Jane Perlmutter, PhD; Angela M. DeMichele, MD; Douglas Yee, MD; Donald A. Berry, PhD; Laura J. Esserman, MD
JAMA Oncology